UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 194

Sortiert nach

A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients

JNCI : Journal of the National Cancer Institute, 2005-04, Vol.97 (7), p.481-488

2005

Link zum Volltext

Verfügbarkeit prüfen

Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial

Radiation oncology (London, England), 2022-12, Vol.17 (1), p.203-203

2022

Link zum Volltext

Verfügbarkeit prüfen

Infection after prostatic transrectal fiducial marker implantation for image guided radiation therapy

Cancer radiothérapie, 2023-05, Vol.27 (3), p.214-218

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial

Clinical and translational radiation oncology, 2023-05, Vol.40, p.100593-100593, Article 100593

2023

Link zum Volltext

Verfügbarkeit prüfen

Sexual and Hormonal Function Recuperation After Cytoreductive Drug Therapy Prior to Prostate Permanent Seeds Brachytherapy: A Randomized Trial (Dutasteride + Bicalutamide Versus LHRH Agonists)

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S123-S123

2015

Link zum Volltext

Verfügbarkeit prüfen

Employment outcomes for recent Canadian radiation oncology graduates

Current oncology (Toronto), 2019-08, Vol.26 (4), p.e510-514

2019

Link zum Volltext

Verfügbarkeit prüfen

Regional Outcome in N2-N3 Patients With Head and Neck Carcinoma in Function of FDG PET/CT Results

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S441-S441

2013

Link zum Volltext

Verfügbarkeit prüfen

Modeling Biochemical Relapse-Free Survival in Intraoperative Planned Low-Dose-Rate Prostate Brachytherapy: A Multicenter Cohort Analysis

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E252-E252

2016

Link zum Volltext

Verfügbarkeit prüfen

Validation of a French-Canadian Version of the Expanded Prostate Cancer Index Composite Instrument (EPIC)

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E531-E532

2016

Link zum Volltext

Verfügbarkeit prüfen

Second Malignancies as First Cause of Death in Localized Prostate Cancer Treated With Radiation Therapy: Data from Two Phase 3 Trials

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S185-S185

2016

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data

Clinical oncology (Royal College of Radiologists (Great Britain)), 2017-03, Vol.29 (3), p.161-170

2017

Link zum Volltext

Verfügbarkeit prüfen

Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786)

Clinical oncology (Royal College of Radiologists (Great Britain)), 2018-09, Vol.30 (9), p.527-533

2018

Link zum Volltext

Verfügbarkeit prüfen

Radiation Therapy With or Without Short-Term Androgen Deprivation Therapy in Intermediate-Risk Prostate Cancer: Results of a Phase 3 Trial

International journal of radiation oncology, biology, physics, 2016, Vol.94 (1), p.4-4

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Permanent Seed Implant Monotherapy With Combined EBRT Plus HDR Boost in Intermediate-Risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S432-S432

2014

Link zum Volltext

Verfügbarkeit prüfen

PD-0423: Impact of technology and learning curve on migration and seed loss in permanent prostate implants

Radiotherapy and oncology, 2014, Vol.111, p.S168-S168

2014

Link zum Volltext

Verfügbarkeit prüfen

SU‐C‐500‐01: Quantifying the Impact of Intra‐Prostatic Calcifications and Seed Orientation in Low‐Dose Rate Prostate Brachytherapy Using Monte‐Carlo Dose Calculations

Medical Physics, 2013-06, Vol.40 (6), p.88-88

2013

Link zum Volltext

Verfügbarkeit prüfen

Post–Biochemical Failure Risk Stratification to Predict Survival in Prostate Cancer: A Recursive Partitioning Analysis

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E192-E192

2015

Link zum Volltext

Verfügbarkeit prüfen

Androgen Deprivation Therapy in Intermediate-Risk Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy: A Multi-institutional Propensity Score Matched Pair Analysis

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S410-S411

2014

Link zum Volltext

Verfügbarkeit prüfen

Validation of NRG Oncology/RTOG 0129 Risk Groups for p16-Positive and p16-Negative Oropharyngeal Squamous Cell Cancer (OPSCC)

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.871-871

2016

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Groups for p16-Positive Oropharyngeal Squamous Cell Cancer (p16-OPSCC) Treated With Chemoradiation Therapy (CRT) in NRG Oncology/RTOG 0129 and 0522

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.873-874

2016

Link zum Volltext

Verfügbarkeit prüfen

OC-0069: HDR brachytherapy boost for prostate: Evaluation of prostate volume impact on dosimetry and toxicity

Radiotherapy and oncology, 2014, Vol.111, p.S26-S26

2014

Link zum Volltext

Verfügbarkeit prüfen

PD-0187: The impact of prostate volume on clinical outcomes in patients with localized prostate cancer treated with HDR boost

Radiotherapy and oncology, 2014, Vol.111, p.S74-S74

2014

Link zum Volltext

Verfügbarkeit prüfen

NRG Oncology/RTOG 0525 Role of Machine Learning Analytic Tools for Survival Prediction of GBM Patients Using Clinical Parameters

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S142-S143

2015

Link zum Volltext

Verfügbarkeit prüfen

Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S199-S200

2015

Link zum Volltext

Verfügbarkeit prüfen

WE‐C‐108‐09: Patient‐Specific Monte Carlo Dosimetry for I–125 Prostate Brachytherapy

Medical Physics, 2013-06, Vol.40 (6), p.476-476

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 194

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(181)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(52)
Science & Technology
(49)
Life Sciences & Biomedicine
(44)
Humans
(34)
Radiology
(34)
Male
(28)
Oncology
(25)
Radiology, Nuclear Medicine & Medical Imaging
(21)
Prostatic Neoplasms - Radiotherapy
(19)
Prostate Cancer
(17)
Biological And Medical Sciences
(16)
Medical Sciences
(13)
Middle Aged
(13)
Aged
(12)
Brachytherapy
(12)
Radiotherapy Dosage
(11)
Dosimetry
(9)
Adult
(7)
Brachytherapy - Methods
(7)
Care And Treatment
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients

Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial

Infection after prostatic transrectal fiducial marker implantation for image guided radiation therapy

Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial

Sexual and Hormonal Function Recuperation After Cytoreductive Drug Therapy Prior to Prostate Permanent Seeds Brachytherapy: A Randomized Trial (Dutasteride + Bicalutamide Versus LHRH Agonists)

Employment outcomes for recent Canadian radiation oncology graduates

Regional Outcome in N2-N3 Patients With Head and Neck Carcinoma in Function of FDG PET/CT Results

Modeling Biochemical Relapse-Free Survival in Intraoperative Planned Low-Dose-Rate Prostate Brachytherapy: A Multicenter Cohort Analysis

Validation of a French-Canadian Version of the Expanded Prostate Cancer Index Composite Instrument (EPIC)

Second Malignancies as First Cause of Death in Localized Prostate Cancer Treated With Radiation Therapy: Data from Two Phase 3 Trials

Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data

Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786)

Radiation Therapy With or Without Short-Term Androgen Deprivation Therapy in Intermediate-Risk Prostate Cancer: Results of a Phase 3 Trial

Comparison of Permanent Seed Implant Monotherapy With Combined EBRT Plus HDR Boost in Intermediate-Risk Prostate Cancer

PD-0423: Impact of technology and learning curve on migration and seed loss in permanent prostate implants

SU‐C‐500‐01: Quantifying the Impact of Intra‐Prostatic Calcifications and Seed Orientation in Low‐Dose Rate Prostate Brachytherapy Using Monte‐Carlo Dose Calculations

Post–Biochemical Failure Risk Stratification to Predict Survival in Prostate Cancer: A Recursive Partitioning Analysis

Androgen Deprivation Therapy in Intermediate-Risk Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy: A Multi-institutional Propensity Score Matched Pair Analysis

Validation of NRG Oncology/RTOG 0129 Risk Groups for p16-Positive and p16-Negative Oropharyngeal Squamous Cell Cancer (OPSCC)

Prognostic Groups for p16-Positive Oropharyngeal Squamous Cell Cancer (p16-OPSCC) Treated With Chemoradiation Therapy (CRT) in NRG Oncology/RTOG 0129 and 0522

OC-0069: HDR brachytherapy boost for prostate: Evaluation of prostate volume impact on dosimetry and toxicity

PD-0187: The impact of prostate volume on clinical outcomes in patients with localized prostate cancer treated with HDR boost

NRG Oncology/RTOG 0525 Role of Machine Learning Analytic Tools for Survival Prediction of GBM Patients Using Clinical Parameters

Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer

WE‐C‐108‐09: Patient‐Specific Monte Carlo Dosimetry for I–125 Prostate Brachytherapy

Suchergebnisse filtern